Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment—A Meta-Analysis and Systematic Review

Early poor outcomes of intraocular inflammation (IOI) after intravitreal brolucizumab (IVB) have negatively affected the use of brolucizumab in clinical routine. We wished to identify factors related to the treatment details of IOI involving the posterior segment resulting from IVB for neovascular A...

Descripción completa

Detalles Bibliográficos
Autores principales: Garweg, Justus G., Keiper, Judith, Pfister, Isabel B., Schild, Christin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380786/
https://www.ncbi.nlm.nih.gov/pubmed/37510788
http://dx.doi.org/10.3390/jcm12144671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380786/
https://www.ncbi.nlm.nih.gov/pubmed/37510788
http://dx.doi.org/10.3390/jcm12144671

Ejemplares similares